Influence of Aqueous Solubility-Enhancing Excipients on the Microstructural Characteristics of Furosemide-Loaded Electrospun Nanofibers.
electrospinning
furosemide
microstructural distinction
morphology
nanofiber
physical-chemical characterization
positron annihilation lifetime spectroscopy
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
23 Apr 2020
23 Apr 2020
Historique:
received:
31
03
2020
accepted:
21
04
2020
entrez:
29
4
2020
pubmed:
29
4
2020
medline:
29
4
2020
Statut:
epublish
Résumé
Electrospun nanofibers were prepared from furosemide-containing hydroxypropyl cellulose and poly(vinylpyrrolidone) aqueous solutions using different solubility enhancers. In one case, a solubilizer, triethanolamine, was applied, while in the other case a pH-modifier, sodium hydroxide, was applied. Scanning electron microscopy (SEM) was carried out for morphological characterization of the fibers. The SEM images indicated similar mean diameter size of the two fibrous formulations. However, in contrast to the NaOH-containing fibers of normal diameter distribution, the triethanolamine-containing fibers showed approximately normal diameter distribution, possibly due to their plasticizing effect and the consequent slightly ribbon-like morphology. Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), powder X-ray diffraction (XRD) and positron annihilation lifetime spectroscopy (PALS) were applied for microstructural characterization. The FTIR measurements confirmed that furosemide salt was formed in both cases. There was no sign of any crystallinity based on the XRD measurements. However, the PALS highlighted the differences in the average o-Ps lifetime values and distributions of the furosemide-loaded fibrous formulations. The two types of electrospun nanofibrous formulations containing amorphous furosemide salt showed similar macrostructures but different microstructural characteristics depending on the type of solubility enhancers, which lead to altered storage stability.
Identifiants
pubmed: 32340196
pii: pharmaceutics12040385
doi: 10.3390/pharmaceutics12040385
pmc: PMC7238267
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Adv Drug Deliv Rev. 2016 May 1;100:85-101
pubmed: 26826438
Eur J Pharm Sci. 2014 Sep 30;61:18-26
pubmed: 24566614
Int J Pharm. 2015 Dec 30;496(2):497-508
pubmed: 26456246
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51
pubmed: 24075980
J Control Release. 2018 Dec 28;292:91-110
pubmed: 30118788
J Pharm Sci. 2015 Jun;104(6):1971-1980
pubmed: 25761921
Curr Pharm Des. 2015;21(15):2021-36
pubmed: 25732659
Int J Pharm. 2009 Oct 20;381(1):1-18
pubmed: 19664700
Int J Pharm. 2015 Oct 15;494(1):516-30
pubmed: 26307263
J Pharm Sci. 2016 Sep;105(9):2527-2544
pubmed: 26886314
Mol Pharm. 2018 Sep 4;15(9):4214-4225
pubmed: 30024759
Int J Biol Macromol. 2014 Jun;67:295-302
pubmed: 24685464
Int J Pharm. 2015 Apr 30;484(1-2):57-74
pubmed: 25701683
Polymers (Basel). 2017 Nov 25;9(12):
pubmed: 30965943
J Pharm Biomed Anal. 2014 Jul;95:139-45
pubmed: 24667568
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 May;12(3):e1601
pubmed: 31692241
Eur J Pharm Biopharm. 2012 May;81(1):131-41
pubmed: 22266263
Acta Pharm Hung. 2013;83(3):96-104
pubmed: 24369588
J Pharm Biomed Anal. 2006 Feb 13;40(2):249-54
pubmed: 16143484
Eur J Pharm Biopharm. 2013 Aug;84(3):616-25
pubmed: 23395969
Carbohydr Polym. 2013 Apr 15;94(1):292-300
pubmed: 23544541
J Pharm Sci. 2015 May;104(5):1767-76
pubmed: 25761776